TrialSite Op-ed author Geert Vanden Bossche warned public health authorities that intervening in a mass pandemic with mass vaccination could have both “detrimental and beneficial…
Northern California researchers representing both University of California, Berkeley and University of California, San Francisco recently uploaded their study results to the preprint server medRxiv declaring that…
University of California, San Francisco (UCSF) researchers focusing on immunotherapies that fight cancer center their attention on emerging engineered smart immune cells can zap solid…
One of the biggest challenges facing clinical trial sponsors and investigational sites centers on the efficient identification, recruitment and ongoing retention of sufficient numbers of…
Autobahn labs, a virtual incubator partnered with top academic and research centers to catalyze early-stage drug discovery and development, recently inked a strategic collaboration deal…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
